Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Helix Science LLC maintains 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single action is situated within 1 distinct art unit, reflecting a concentrated focus for the company's current legal proceedings. For practitioners, this concentration means that prosecution strategy is currently tied to the specific requirements and trends of a single specialized division at the USPTO.
The portfolio involves 1 distinct examiner, ROBERTS, LEZAH, who is also identified as the busiest examiner with 1 pending office action. Because there is 1 distinct examiner for the 1 pending action, the company's immediate prosecution success depends on the interactions with this specific individual. This creates a singular point of contact for all active matters, allowing for a focused approach to addressing examiner concerns.
With 1 pending office action and 1 distinct examiner, the data shows a direct relationship between active cases and USPTO personnel. This simplicity in the prosecution profile suggests that the company is not currently managing a high volume of simultaneous disputes. The focus on Biotechnology & Pharmaceuticals ensures that the legal strategy remains aligned with the specific patentability standards of that technology sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBERTS, LEZAH | 1 | 48.4% | +35.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19055744 | Composition for the control of oral malodor compounds | ROBERTS, LEZAH | 72d overdue |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19055744 | Composition for the control of oral malodor compounds | ROBERTS, LEZAH | 1612 | §103§112DP | Final Rejection | 72d overdue | Pending | Feb 18, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial